154 related articles for article (PubMed ID: 21553236)
21. Tissue expression of retinoic acid receptor alpha and CRABP2 in metastatic nephroblastomas.
Percicote AP; Mardegan GL; Gugelmim ES; Ioshii SO; Kuczynski AP; Nagashima S; de Noronha L
Diagn Pathol; 2018 Jan; 13(1):9. PubMed ID: 29378601
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical detection of telomerase reverse transcriptase (TERT) protein in benign and malignant tumor cells of the breast.
Ikeda S; Shibata T; Funakoshi N
Rinsho Byori; 2005 Jun; 53(6):487-93. PubMed ID: 16026073
[TBL] [Abstract][Full Text] [Related]
23. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
[TBL] [Abstract][Full Text] [Related]
24. MIB-1 (KI-67) proliferation index and cyclin-dependent kinase inhibitor p27(Kip1) protein expression in nephroblastoma.
Ghanem MA; Van der Kwast TH; Sudaryo MK; Mathoera RB; van den Heuvel MM; Al-Doray AA; Nijman RM; van Steenbrugge GJ
Clin Cancer Res; 2004 Jan; 10(2):591-7. PubMed ID: 14760081
[TBL] [Abstract][Full Text] [Related]
25. Stromal-type Nephroblastoma with or without Anaplasia in Two Hedgehogs (Atelerix albiventris).
Ueda K; Imada T; Ueda A; Imada M; Ozaki K
J Comp Pathol; 2019 Oct; 172():48-52. PubMed ID: 31690414
[TBL] [Abstract][Full Text] [Related]
26. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.
Dome JS; Chung S; Bergemann T; Umbricht CB; Saji M; Carey LA; Grundy PE; Perlman EJ; Breslow NE; Sukumar S
Cancer Res; 1999 Sep; 59(17):4301-7. PubMed ID: 10485476
[TBL] [Abstract][Full Text] [Related]
27. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma.
Cho WC; Wang WL; Milton DR; Ingram DR; Nagarajan P; Curry JL; Ivan D; Lazar AJ; Hwu WJ; Prieto VG; Torres-Cabala CA; Aung PP
Arch Pathol Lab Med; 2021 Jul; 145(7):842-850. PubMed ID: 33053175
[TBL] [Abstract][Full Text] [Related]
28. A rare case of a Wilms tumor: case report.
Singer CE; Marinău LD; Coşoveanu CS; Streba L; Petrescu IO; Stepan MD; Stoica GA; Traşcă DM
Rom J Morphol Embryol; 2018; 59(4):1287-1292. PubMed ID: 30845314
[TBL] [Abstract][Full Text] [Related]
29. Tissue expression of MLH1, PMS2, MSH2, and MSH6 proteins and prognostic value of microsatellite instability in Wilms tumor: experience of 45 cases.
Diniz G; Aktas S; Cubuk C; Ortac R; Vergin C; Olgun N
Pediatr Hematol Oncol; 2013 May; 30(4):273-84. PubMed ID: 23570624
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia.
Cheah PL; Looi LM; Chan LL
Histopathology; 1996 Jan; 28(1):49-54. PubMed ID: 8838120
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of nuclear unrest and p53 immunostaining in Wilms' tumor.
Salama A; Kamel A
J Egypt Natl Canc Inst; 2011 Mar; 23(1):31-9. PubMed ID: 22099934
[TBL] [Abstract][Full Text] [Related]
32. Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532.
Fernandez CV; Perlman EJ; Mullen EA; Chi YY; Hamilton TE; Gow KW; Ferrer FA; Barnhart DC; Ehrlich PF; Khanna G; Kalapurakal JA; Bocking T; Huff V; Tian J; Geller JI; Grundy PE; Anderson JR; Dome JS; Shamberger RC
Ann Surg; 2017 Apr; 265(4):835-840. PubMed ID: 27811504
[TBL] [Abstract][Full Text] [Related]
33. Expression and prognostic value Of CD44 isoforms in nephroblastoma (Wilms tumor).
Ghanem MA; Van Steenbrugge GJ; Van Der Kwast TH; Sudaryo MK; Noordzij MA; Nijman RJ
J Urol; 2002 Aug; 168(2):681-6. PubMed ID: 12131349
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of Wilms' tumor in eastern China: 10 years of experience at a single center.
Yao W; Li K; Xiao X; Gao J; Dong K; Xiao X; Lv Z
J Invest Surg; 2012 Jun; 25(3):181-5. PubMed ID: 22583015
[TBL] [Abstract][Full Text] [Related]
35. [Immunohistochemical evaluation of the percentage of proliferating neoplastic cells of Wilms' tumor in children by means of the MIB-1 monoclonal antibody].
Juszkiewicz P
Ann Acad Med Stetin; 1997; 43():113-27. PubMed ID: 9471911
[TBL] [Abstract][Full Text] [Related]
36. Preliminary observations regarding the expression of collagen triple helix repeat-containing 1 is an independent prognostic factor for Wilms' tumor.
Qi C; Hu Y; Yang F; An H; Zhang J; Jin H; Guo F
J Pediatr Surg; 2016 Sep; 51(9):1501-6. PubMed ID: 27230801
[TBL] [Abstract][Full Text] [Related]
37. Tumour cell proliferation rate as determined by MIB-1 antibody in Wilms' tumour.
Juszkiewicz P; Tuziak T; Zbisławski W; Liebhard M; Chosia M
Pol J Pathol; 1997; 48(2):113-9. PubMed ID: 9278108
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of telomerase in patients with non-small cell lung cancer: prediction of metastasis and prognostic significance.
Aras G; Kanmaz D; Urer N; Purisa S; Kadakal F; Yentürk E; Tuncay E
Anticancer Res; 2013 Jun; 33(6):2643-50. PubMed ID: 23749922
[TBL] [Abstract][Full Text] [Related]
39. Increased tissue factor expression and poor nephroblastoma prognosis.
Maciel EO; Carvalhal GF; da Silva VD; Batista EL; Garicochea B
J Urol; 2009 Oct; 182(4):1594-9. PubMed ID: 19683742
[TBL] [Abstract][Full Text] [Related]
40. Factors affecting lymph node sampling patterns and the impact on survival of lymph node density in patients with Wilms tumor: a Surveillance, Epidemiology, and End Result (SEER) database review.
Walker JP; Johnson JS; Eguchi MM; Saltzman AF; Cockburn M; Cost NG
J Pediatr Urol; 2020 Feb; 16(1):81-88. PubMed ID: 31791906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]